Mie University · Graduate School of Medical Sciences · 教授

Research keywordsB-cell lymphoma・diffuse large B-cell lymphoma・indolent lymphoma・R-CHOP chemotherapy・radioimmunotherapy・histone deacetylase inhibitors・multiple myeloma・hematologic malignancies

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• 1. Watanabe T, Tobinai K, Matsumoto M, Suzuki K, Sunami K, Ishida T, Ando K, Chou T, Ozaki S, Taniwaki M, Uike N, Shibayama H, Hatake K, Izutsu K, Ishikawa T, Shumiya Y, Kashihara T, Iida S. A phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myeloma. Br J Haematol 172:745-756, 2016.2016 · 主な業績等
• 3. Watanabe T, Mitsuhashi M, Sagawa M, Ri M, Suzuki K, Abe M, Ohmachi K, Nakagawa Y, Nakamura S, Chosa M, Iida S, Kizaki M. Phytohemagglutinin-induced IL2 mRNA in whole blood can predict bortezomib-induced peripheral neuropathy for multiple myeloma patients. Blood Cancer J Oct 4;3:e150. doi: 10.1038/bcj.2013.47.2013 · 主な業績等
• 5. Watanabe T, Tobinai K, Shibata T, Tsukasaki K, Morishima Y, Maseki N, Kinoshita T, Suzuki T, Yamaguchi M, Ando K, Ogura M, Taniwaki M, Uike N, Takeuchi K, Nawano S, Terauchi T, Hotta T. Phase II/III Study of R-CHOP-21 Versus R-CHOP-14 for Untreated Indolent B-Cell Non-Hodgkin's Lymphoma: JCOG 0203 Trial. J Clin Oncol 29: 3990-3998, 2011.2011 · 主な業績等
• 4. Fukuhara S, Watanabe T, Munakata W, Mori M, Maruyama D, Kim SW, Kobayashi Y, Taniguchi H, Maeshima AM, Tanosaki R, Matsuno Y, Tobinai K. Bulky disease has an impact on outcomes in primary diffuse large B-cell lymphoma of the breast: a retrospective analysis at a single institution. Eur J Haematol 87: 434-440, 2011.2011 · 主な業績等

• リツキシマブ併用悪性リンパ腫治療中のB型肝炎ウイルス再活性化への標準的対策法の確立及びリスク因子の解明に関する研究
• 進行期難治性B細胞リンパ腫に対する治癒を目指した自家末梢血幹細胞移植併用大量化学療法の確立に関する研究
• Abscopal 効果の効果的な照射/ワクチン最適注射臓器の探索
• リツキシマブ+ステロイド併用悪性リンパ腫治療中のB型肝炎ウイルス再活性化への対策に関する研究

• Official profile